Evaluation of inducible expression of ERCC1 as a biomarker of drug response in human colorectal cancer cell lines. Background: Although in use for almost 30 years, the clinical value of CEA as the ...

“[...] these inexpensive, widely available tests with rapid turnaround times and relatively short half-lives (CEA, CA-125, and CA19-9) are perfectly situated to ...

A new research paper was published in Oncotarget's Volume 15 on June 13, 2024, entitled, "Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management ...

Please provide your email address to receive an email when new articles are posted on . Elevated postoperative serum carcinoembryonic antigen increased risk for recurrence, especially within the first ...

Improved means of identifying patients with pancreatic adenocarcinoma who do not benefit from resection would protect these individuals from unnecessary pancreatectomy. Kelly et al., from the Memorial ...

Helicobacter pylori infection and the risk of colorectal cancer: A meta-analysis of epidemiologic evidence. Background: Carcinoembryonic antigen (CEA) is a widely used tumor marker for surveillance in ...

A novel intelligent biosensing platform consisting of quantum dots luminescence and biochip with machine vision algorithm is proposed for point-of-care carcinoembryonic antigen (CEA) protein ...

Tumor marker blood tests may help inform various aspects of cancer care, including diagnosis, staging, treatment planning, and outlook. However, they’re often not the only diagnostic tests used. If ...